We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
+0.32%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$1.45B
AUM Growth
-$178M
Cap. Flow
-$598M
Cap. Flow %
-41.13%
Top 10 Hldgs %
49.58%
Holding
91
New
6
Increased
8
Reduced
20
Closed
16

Sector Composition

Rank Sector Weight
1 Healthcare 14.91%
2 Financials 7.22%
3 Technology 6.72%
4 Communication Services 6.33%
5 Energy 2.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARWR icon
26
Arrowhead Research
ARWR
$12.1B
$10.9M 0.75%
2,047,782
TNK icon
27
Teekay Tankers
TNK
$2.63B
$10.9M 0.75%
456,847
+229,173
+101% +$6.55M
HOUS
28
DELISTED
Anywhere Real Estate
HOUS
$10.6M 0.73%
365,645
-34,355
-9% -$1.13M
TSM icon
29
PUT
TSMC
TSM
$2.09T
$10.5M 0.72%
400,000
ICPT
30
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$10.4M 0.72%
73,243
-6,801
-8% -$992K
EPZM
31
DELISTED
Epizyme, Inc
EPZM
$9.95M 0.69%
971,946
-209,298
-18% -$2.33M
SCTY
32
DELISTED
SolarCity Corporation
SCTY
$9.73M 0.67%
406,816
SCTY
33
PUT
DELISTED
SolarCity Corporation
SCTY
$9.72M 0.67%
406,000
AVXS
34
DELISTED
AveXis, Inc. Common Stock
AVXS
$8.96M 0.62%
242,756
BRFS
35
DELISTED
BRF SA
BRFS
$8.46M 0.58%
607,112
SRPT icon
36
Sarepta Therapeutics
SRPT
$1.66B
$7.84M 0.54%
411,077
-38,449
-9% -$712K
BMRN icon
37
BioMarin Pharmaceuticals
BMRN
$11.5B
$7.57M 0.52%
97,246
-9,043
-9% -$769K
XNCR icon
38
Xencor
XNCR
$1.44B
$7.35M 0.51%
386,925
FIT
39
DELISTED
Fitbit, Inc. Class A common stock
FIT
$7.08M 0.49%
+579,502
New +$8.58M
BLCM
40
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$6.58M 0.45%
50,794
ADAP
41
DELISTED
Adaptimmune Therapeutics
ADAP
$6.39M 0.44%
783,645
ONC
42
BeOne Medicines Ltd
ONC
$33.8B
$5.07M 0.35%
170,000
GLNG icon
43
Golar LNG
GLNG
$4.95B
$4.65M 0.32%
300,283
GNMX
44
DELISTED
Aevi Genomic Medicine Inc
GNMX
$4.56M 0.31%
848,800
-18,808
-2% -$98.8K
MFRM
45
DELISTED
MATTRESS FIRM HLDG CORP COM STK (DE)
MFRM
$4.39M 0.3%
+130,738
New +$4.79M
HALO icon
46
Halozyme
HALO
$9.72B
$4.32M 0.3%
500,449
-193,987
-28% -$1.91M
ZX
47
DELISTED
China Zenix Auto Internatl Ltd
ZX
$3.86M 0.27%
6,074,805
ASMB icon
48
Assembly Biosciences
ASMB
$506M
$3.74M 0.26%
67,300
+5,575
+9% +$366K
RGNX icon
49
Regenxbio
RGNX
$623M
$3.4M 0.23%
424,368
FRO icon
50
Frontline
FRO
$8.75B
$3.2M 0.22%
+408,341
New +$3.36M

Similar funds

QVT Financial's Q2 2016 Portfolio in Review

As of Q2 2016, QVT Financial held 91 positions worth $1.45B, down 11% from $1.63B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

QVT Financial withdrew a net $598M in Q2 2016, closing 16 positions and reducing 20 holdings. Its most notable exit was YOUKU TUDOU INC.(CAYMAN ISLS), an estimated $22.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, QVT Financial opened a new position in Fitbit, Inc. Class A common stock worth $7.08M.

  • QVT Financial's largest Q2 2016 buy was Fitbit, Inc. Class A common stock: 579,502 shares worth $7.08M.
  • QVT Financial added most to QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q2 2016, an estimated $15.1M increase.
  • QVT Financial's biggest Q2 2016 reduction was Marvell Technology, cutting an estimated $25.1M.
  • QVT Financial fully exited YOUKU TUDOU INC.(CAYMAN ISLS) in Q2 2016, selling an estimated $22.1M.
  • QVT Financial's ten largest holdings make up 50% of its $1.45B portfolio in Q2 2016.
  • QVT Financial opened 6 new positions and closed 16 in Q2 2016.
  • QVT Financial's portfolio value fell 11% quarter-over-quarter to $1.45B.

Based on QVT Financial's 13F filing for Q2 2016, filed 15 Aug 2016.